Hantavirus infection overview

Jump to navigation Jump to search

Hantavirus infection Microchapters

Home

Patient Information

Hantavirus cardiopulmonary syndrome (HCPS) (patient information)
Hemorrhagic fever with renal syndrome (HFRS) (patient information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hantavirus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future Investigational Therapies

Case Studies

Case #1

Hantavirus infection overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hantavirus infection overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hantavirus infection overview

CDC on Hantavirus infection overview

Hantavirus infection overview in the news

Blogs on Hantavirus infection overview

Directions to Hospitals Treating Hantavirus pulmonary syndrome

Risk calculators and risk factors for Hantavirus infection overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hantavirus pulmonary syndrome (HPS) is a deadly disease from rodents.

Historical Perspective

In May 1993, an outbreak of an unexplained pulmonary illness occurred in the southwestern United States, in an area shared by Arizona, New Mexico, Colorado and Utah known as "The Four Corners." A young, physically fit Navajo man suffering from shortness of breath was rushed to a hospital in New Mexico and died very rapidly.

Classification

Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE).[1]

Pathophysiology

Hantavirus is usually transmitted via the inhalation of aerosolized viral antigens or rodent bites. The incubation period of hantavirus infection is of 9 to 33 days. Following inhalation, the virus replicates in pulmonary macrophages and dendritic cells. The primary target cells of hantavirus infection are endothelial cells of capillaries. Infection is followed by impairment of the barrier function of endothelial cells, fluid extravasation, and subsequent organ failure.

Causes

Hantaviruses belong to the bunyaviridae family of viruses. There are 5 genera within the bunyaviridae family: bunyavirus, phlebovirus, nairovirus, tospovirus, and hantavirus. Each is made up of negative-sensed, single-stranded RNA viruses. All these genera include arthropod-borne viruses, with the exception of hantavirus, which is a genus of rodent-borne agents.

Differentiating Hantavirus from other Diseases

Epidemiology and Demographics

Hantavirus infection has a diverse epidemiology and demographics due to the vast number of viruses classified under hantaviruses. The total number of hantavirus pulmonary syndrome (HPS) cases reported in the United States from 2004-2015 is 323. HPS cases have been reported in 30 states, including most of the western half of the country and some eastern states as well. Over half of the confirmed cases have been reported from areas outside the Four Corners area. The mean age of confirmed HPS cases is 38 years (range: 5 to 84 years).[2]

Risk Factors

Little is known about activities that lead to a greater risk of infection. However, an early case-control study suggests that increased numbers of rodents in the household is the strongest risk factor for infection.

Screening

There are no screening recommendations for hantavirus infection.

Natural History, Complications and Prognosis

If hantavirus infection left untreated, it may result in multi-organ failure and death. Possible complications include, acute encephalomyelitis, Pituitary hemorrhage, Glomerulonephritis, Pulmonary edema, acute respiratory distress syndrome, Disseminated intravascular coagulation, Thrombocytopenia, and shock. Its prognosis depends on the extent of the diseases. The hantavirus cardiopulmonary syndrome (HCPS) has 38% mortality rate but, hemorrhagic fever with renal syndrome (HFRS) has a better prognosis with 1 to 15% mortality rate.[3][4][5]

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

A positive serological test result, evidence of viral antigen in tissue by immunohistochemistry, or the presence of amplifiable viral RNA sequences in blood or tissue, with compatible history of HPS, is considered diagnostic for HPS.

X ray

CT scan

MRI

Ultrasound

Other Imaging findings

Other Diagnostic Studies

Treatment

Medical Therapy

There is no specific treatment, cure, or vaccine for hantavirus infection. However, we do know that if infected individuals are recognized early and receive medical care in an intensive care unit, they may do better.

Surgery

Primary Prevention

Eliminate or minimize contact with rodents in your home, workplace, or campsite. Seal up holes and gaps in your home or garage. Place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food. Recent research results show that many people who became ill with HPS developed the disease after having been in frequent contact with rodents and/or their droppings around a home or a workplace. On the other hand, many people who became ill reported that they had not seen rodents or rodent droppings at all. Therefore, if you live in an area where the carrier rodents are known to live, try to keep your home, vacation place, workplace, or campsite clean.

Secondary Prevention

References

  1. Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X (2017). "Hantavirus infection: a global zoonotic challenge". Virol Sin. 32 (1): 32–43. doi:10.1007/s12250-016-3899-x. PMID 28120221.
  2. "Hantavirus Pulmonary Syndrome (HPS) Cases, by State of Exposure | Hantavirus | DHCPP | CDC".
  3. Crowley MR, Katz RW, Kessler R, Simpson SQ, Levy H, Hallin GW, Cappon J, Krahling JB, Wernly J (1998). "Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation". Crit. Care Med. 26 (2): 409–14. PMID 9468181.
  4. Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA (2006). "Diagnosis and treatment of new world hantavirus infections". Curr. Opin. Infect. Dis. 19 (5): 437–42. doi:10.1097/01.qco.0000244048.38758.1f. PMID 16940866.
  5. Levy H, Simpson SQ (1994). "Hantavirus pulmonary syndrome". Am. J. Respir. Crit. Care Med. 149 (6): 1710–3. doi:10.1164/ajrccm.149.6.8004332. PMID 8004332.

Template:WH Template:WikiDoc Sources